The Role of Gammaherpesviruses in Cancer Pathogenesis

Overview

Journal Pathogens

Date 2016 Feb 11

PMID 26861404

Citations 70

Authors

Hem Chandra Jha

Shuvomoy Banerjee

Erle S Robertson

Affiliations

Soon will be listed here.

Abstract

Worldwide, one fifth of cancers in the population are associated with viral infections. Among them, gammaherpesvirus, specifically HHV4 (EBV) and HHV8 (KSHV), are two oncogenic viral agents associated with a large number of human malignancies. In this review, we summarize the current understanding of the molecular mechanisms related to EBV and KSHV infection and their ability to induce cellular transformation. We describe their strategies for manipulating major cellular systems through the utilization of cell cycle, apoptosis, immune modulation, epigenetic modification, and altered signal transduction pathways, including NF-kB, Notch, Wnt, MAPK, TLR, etc. We also discuss the important EBV latent antigens, namely EBNA1, EBNA2, EBNA3's and LMP's, which are important for targeting these major cellular pathways. KSHV infection progresses through the engagement of the activities of the major latent proteins LANA, v-FLIP and v-Cyclin, and the lytic replication and transcription activator (RTA). This review is a current, comprehensive approach that describes an in-depth understanding of gammaherpes viral encoded gene manipulation of the host system through targeting important biological processes in viral-associated cancers.

Citing Articles

Interplay of aurora kinase a functional residues and Epstein-barr Nuclear Antigen 1 in Epstein-barr virus associated Gastric cancer using AGS cells.

Varshney N, Singh S, Kandpal M, Saini V, Roberston E, Jha H BMC Cancer. 2025; 25(1):143.

PMID: 39856614 PMC: 11762537. DOI: 10.1186/s12885-024-13260-z.

Understanding Metabolic Pathway Rewiring by Oncogenic Gamma Herpesvirus.

Choi U, Lee S J Microbiol Biotechnol. 2024; 34(11):2143-2152.

PMID: 39403716 PMC: 11637867. DOI: 10.4014/jmb.2407.07039.

Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response.

Zhang H, Fu L, Leiliang X, Qu C, Wu W, Wen R Cancer Commun (Lond). 2024; 44(10):1130-1167.

PMID: 39087354 PMC: 11483591. DOI: 10.1002/cac2.12597.

Nontypeable Haemophilus influenzae challenge during gammaherpesvirus infection enhances viral reactivation and latency.

Huss N, Majeed S, Wills B, Tarakanova V, Brockman K, Jondle C Virology. 2024; 597:110153.

PMID: 38941745 PMC: 11257779. DOI: 10.1016/j.virol.2024.110153.

Dynamics of the Herpes simplex virus DNA polymerase holoenzyme during DNA synthesis and proof-reading revealed by Cryo-EM.

Gustavsson E, Grunewald K, Elias P, Hallberg B Nucleic Acids Res. 2024; 52(12):7292-7304.

PMID: 38806233 PMC: 11229320. DOI: 10.1093/nar/gkae374.

References

Groves A, Cotter M, Subramanian C, Robertson E . The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters. J Virol. 2001; 75(19):9446-57. PMC: 114512. DOI: 10.1128/JVI.75.19.9446-9457.2001. View

Schepers A, Ritzi M, Bousset K, Kremmer E, Yates J, Harwood J . Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J. 2001; 20(16):4588-602. PMC: 125560. DOI: 10.1093/emboj/20.16.4588. View

Heather J, Flower K, Isaac S, Sinclair A . The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1. J Gen Virol. 2009; 90(Pt 6):1450-1454. PMC: 2885059. DOI: 10.1099/vir.0.007922-0. View

Akira S, Hemmi H . Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett. 2003; 85(2):85-95. DOI: 10.1016/s0165-2478(02)00228-6. View

Hammerschmidt W, Sugden B . Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature. 1989; 340(6232):393-7. DOI: 10.1038/340393a0. View

Hayward S, Liu J, Fujimuro M . Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses. Sci STKE. 2006; 2006(335):re4. DOI: 10.1126/stke.3352006re4. View

Saha A, Halder S, Upadhyay S, Lu J, Kumar P, Murakami M . Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1. PLoS Pathog. 2011; 7(2):e1001275. PMC: 3037348. DOI: 10.1371/journal.ppat.1001275. View

Coverdale L, Martyniuk C, Trudeau V, Martin C . Differential expression of the methyl-cytosine binding protein 2 gene in embryonic and adult brain of zebrafish. Brain Res Dev Brain Res. 2004; 153(2):281-7. DOI: 10.1016/j.devbrainres.2004.08.009. View

Mihaylova M, Shaw R . The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 2011; 13(9):1016-23. PMC: 3249400. DOI: 10.1038/ncb2329. View

10.

Cotter 2nd M, Robertson E . The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology. 1999; 264(2):254-64. DOI: 10.1006/viro.1999.9999. View

11.

Saha A, Jha H, Upadhyay S, Robertson E . Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection. Proc Natl Acad Sci U S A. 2015; 112(37):E5199-207. PMC: 4577197. DOI: 10.1073/pnas.1503806112. View

12.

Rymo L . Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells. J Virol. 1979; 32(1):8-18. PMC: 353521. DOI: 10.1128/JVI.32.1.8-18.1979. View

13.

Verma S, Borah S, Robertson E . Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J Virol. 2004; 78(19):10348-59. PMC: 516419. DOI: 10.1128/JVI.78.19.10348-10359.2004. View

14.

Polster B, Pevsner J, Hardwick J . Viral Bcl-2 homologs and their role in virus replication and associated diseases. Biochim Biophys Acta. 2004; 1644(2-3):211-27. DOI: 10.1016/j.bbamcr.2003.11.001. View

15.

He C, Klionsky D . Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009; 43:67-93. PMC: 2831538. DOI: 10.1146/annurev-genet-102808-114910. View

16.

Boshoff C, Chang Y . Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus. Annu Rev Med. 2001; 52:453-70. DOI: 10.1146/annurev.med.52.1.453. View

17.

King W, Dambaugh T, Heller M, Dowling J, Kieff E . Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion. J Virol. 1982; 43(3):979-86. PMC: 256208. DOI: 10.1128/JVI.43.3.979-986.1982. View

18.

Haddad L, Hajj H, Abou-Merhi R, Kfoury Y, Mahieux R, El-Sabban M . KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells. Leukemia. 2007; 22(4):826-34. DOI: 10.1038/sj.leu.2405081. View

19.

Nyfeler B, Bergman P, Triantafellow E, Wilson C, Zhu Y, Radetich B . Relieving autophagy and 4EBP1 from rapamycin resistance. Mol Cell Biol. 2011; 31(14):2867-76. PMC: 3133392. DOI: 10.1128/MCB.05430-11. View

20.

Uppal T, Jha H, Verma S, Robertson E . Chromatinization of the KSHV Genome During the KSHV Life Cycle. Cancers (Basel). 2015; 7(1):112-42. PMC: 4381254. DOI: 10.3390/cancers7010112. View